General MedicationsINTRAOCULARStandard
MIOSTAT
CARBACHOL
Standard Dose
0.01%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MIOSTAT is listed in Drugs@FDA under application 016968 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CARBACHOL Form and strength SOLUTION;INTRAOCULAR - 0.01% Sponsor ALCON Submission history Latest submission status date: 2016-01-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview MIOSTAT is listed in Drugs@FDA under application 016968 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CARBACHOL Form and strength SOLUTION;INTRAOCULAR - 0.01% Sponsor ALCON Submission history Latest submission status date: 2016-01-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.